INFLUENCE OF A BIOLOGICALLY ACTIVE COMPOUND FROM SUBSTITUTED THIADIAZINES ON TRANSAMINASE ACTIVITY IN MYOCARDIAL HOMOGENATE IN EXPERIMENTAL MYOCARDIAL INFARCTION

Authors

  • Chupakhin Oleg The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS
  • Sarapultsev Alexey Institute of Immunology and Physiology of the Ural Branch of the RAS
  • Chereshneva Margarita The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS
  • Gette Irina The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS
  • Sidorova Larisa The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS
  • Danilova Irina The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS
  • Sarapultsev Petr The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS

Keywords:

Enzymes, L-17 compound, Myocardial infarction, Thiadiazines, Tissue enzymes

Abstract

Objective: Earlier works have reported on the effectiveness of the compounds of the group of substituted 5R1, 6R2, 3,4-thiadiasine-2-amines for treating experimental myocardial infarction, conditioned by the immune-modifying action of the compound. The purpose of this study was to evaluate the action of the L17 compound of the group of substituted 5R1, 6R2, 3,4-thiadiasine-2-amines on the extent of injury and the possible recurrence of experimental myocardial infarction by the dynamic assessment of transaminase activity in blood and myocardial homogenate (tissue).

Methods: Modelling of myocardial infarction in rats was performed in accordance with the author's modification of the standard ligation model. Tissue enzyme activity of LDH and CK-MB was evaluated at days 1, 7, and 14.

Results: According to the results, the decrease in LDH 1-2 activity in tissue (after experimental myocardial infarction) corresponded to the increase in enzyme activity in blood on the first day of the experiment. However, on the seventh day of the experiment, the decrease of LDH 1-2 activities in the tissue of animals treated with L17 compound corresponded with the decrease of LDH activity in blood, while in non-treated animals the relation between the enzyme levels in blood and tissue was typical for the onset of MI.

Conclusions: The evaluation of enzyme levels in myocardial tissue confirms previouslyreported data that the administration of a thiadiazine compounds prevents the recurrence and decreases the size of experimental myocardial infarction.

 

Downloads

Download data is not yet available.

References

McLean AS, Huang SJ, Salter M. Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient. Crit Care 2008;12(3):215.

Volkov NI, NesenJeN, Osipenko AA, Korsun SN. Biohimijamyshechnojdejatel'nost [Biochemistry of muscle activity]. Moscow: Olimpijskaja literatura; 2000.

Berjozov TG, Korovkin BF. Biologicheskajahimija: Uchebnik [Biological Chemistry: Textbook]. 3rd ed. Moscow: Medicina; 1998.

Sarapultsev P, Chupakhin O, Sarapultsev A, Rantsev M, Sidorova L, Medvedeva S, et al. New insights in to the treatment of myocardial infarction. Int J Exp Pathol 2012;93(1):18–23.

Sarapultsev AP, Chupakhin ON, Sarapultsev PA, Rantsev MA, Medvedeva SU, Sidorova LP, et al. Modulation of inflammatory response improves myocardial infarct healing in rats. Curr Pharm Des 2014;20(12):1980-6.

Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 1980;26(9):1241-50.

Logvinova YuS, Vasilyeva TM, Makarov VA, Chupakhin ON, Sidorova LP, Perova NM, et al. Experimental study of antiaggregation effect of 2-cycloalkyl-amino-5-phenyl-1,3,4-5H(C2H5)-thiadiazines in vitro. Hematol Transfusiol 2013;58(2):37-40.

Vakhnina NA, Alisultanova NJ, Shadrina VD, Bojko ER, Sidorova LP, Chupakhin ON. Succinate dehydrogenase activity in rat liver. World Sci Discoveries 2014;2(50):44-55.

Sarapultsev PA, Sarapultsev AP, Sidorova LP. Influence of apoptosis activation on healing after myocardial infarction. Bull Ural Med Acad Sci 2014;3(49):38-9.

Guide for the Care and Use of Laboratory Animals. Washington DC: The National Academies Press; 1996.

Flecknell P. Laboratory animal anaesthesia. 3rd ed. London, UK: Academic Press; 2009.

Swindle MM, Adams RJ. editors. Experimental surgery and physiology: induced animal models of human diseases. Baltimore: Williams & Wilkins; 1988.

Levy M, Heels-Ansdell D, Hiralal R, Bhandari M, Guyatt G, Yusuf S, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 2011;114(4):796-806.

Komarov FI, Korovkin BF. Biohimicheskieissledovanija v klinike [Biochemical studies in the clinic]. Elista: Dzhangar; 2001.

Notova SV, Duskaeva AH, Miroshnikov SV. Evaluation of influence of dietary stress on psychophysiological and metabolic indicators. Vestnik OSU 2012;10(146):54-7.

Titov VN, Ameljushkina VA, Kotkina TI, Shaposhnikov AV. Lactate dehydrogenase in the diagnosis of myocardial infarction: diagnostic and methodological aspects. Lab Delo 1988;11:31-41.

Cabaniss CD. Creatine Kinase. In: Walker HK, Hall WD, Hurst JW. editors. Сlinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990.

Korovkin BF. Fermenty v diagnostikeinfarktamiokarda [Enzymes in the diagnosis of myocardial infarction]. Leningrad, USSR: Medicina; 1965.

Valentine BA, Blue JT, Shelley SM, Cooper BJ. Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog. J Vet Intern Med 1990;4:140–3.

Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027-32.

Sirkin AL. Infarktmiokarda [Myocardial infarction]. Moscow, Russia: Medicinskoe informacionnoe agentstvo; 1998.

Panteghini M. Acute coronary syndrome: biochemical strategiesin the troponin era. Chest 2002;122:1428-35.

Rybak OK, Rakovskij ME, Ivannikova NP, Sorokina EN, Morozov IA, DovgalevskijJaP. Recurrence of myocardial infarction and time of day. Russian J Cardiology 2003;1:5-8.

Bizenkova MN, Chesnokova NP, Romancev MG. Principles of medicamental correction of metabolic disorders at ischemic injuries of myocardium. Adv Curr Nat Sci 2006;5:9-12.

Thompson PL, Fletcher EE, Katavatis V. Enzymatic indices of myocardial necrosis: influence on short-and long-term prognosis after myocardial infarction. Circulation 1979;59(1):113-9.

Inoue M, Hori M, Nishimoto Y, Fukui S, Abe H, Wada, et al. Immunological determination of serum m-AST activity in patients with acute myocardial infarction. Br Heart J 1978;40(11):1251-6.

Patel SS, Verma NK, Rathore B, Nayak G, Singhai AK, Singh P. Cardioprotective effect of Bombaxceiba flowers against acute adriamycin-induced myocardial infarction in rats. Rev Bras Farmacogn 2011;21(4):704-9.

Published

01-06-2015

How to Cite

Oleg, C., S. Alexey, C. Margarita, G. Irina, S. Larisa, D. Irina, and S. Petr. “INFLUENCE OF A BIOLOGICALLY ACTIVE COMPOUND FROM SUBSTITUTED THIADIAZINES ON TRANSAMINASE ACTIVITY IN MYOCARDIAL HOMOGENATE IN EXPERIMENTAL MYOCARDIAL INFARCTION”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 6, June 2015, pp. 147-51, https://journals.innovareacademics.in/index.php/ijpps/article/view/5727.

Issue

Section

Original Article(s)